We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Jenner, E. An inquiry into the causes and effects of the variolae vaccinae. London: Sampson Low, 1798.Google Scholar
2
2.Baxby, D. The genesis of Edward Jenner's Inquiry of 1798; a comparison of the two unpublished manuscripts and the published version. Med Hist1985; 29193–9.CrossRefGoogle ScholarPubMed
4.Plotkin, S, Fantini, B, eds. Vaccinia, vaccination, vaccinology: Jenner, Pasteur, and their successors. Paris: Elsevier, 1996.Google Scholar
5
5.Pastoret, PP, Brochier, B. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: a link between Jenner and Pasteur. Epidemiol Infect1996; 116: 235–240.CrossRefGoogle ScholarPubMed
6
6.Limbach, KJ, Paoletti, E. Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiol Infect1996; 116: 241–256.CrossRefGoogle ScholarPubMed
7
7.Baxby, D. Jenner's smallpox vaccine: the riddle of vaccinia virus and its origin. London: Heinemann Educational Books, 1981.Google Scholar
8
8.Jenner, E. Further observations on the variolae vaccinae. London: Shury, 1799.Google ScholarPubMed
10.Fenner, F, Henderson, DA, Arita, I, Jezek, Z, Ladnyj, ID. Smallpox and its eradication. Geneva: WHO, 1988.Google Scholar
11
11.Panicali, D, Paoletti, E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus DNA into the DNA of infectious vaccinia virus. Proc Soc Natl Acad Sci USA1982; 79: 7415–9.CrossRefGoogle ScholarPubMed
13.Baxby, D. Recombinant poxvirus vaccines. Rev Med Microbiol1993; 4: 80–8.CrossRefGoogle Scholar
14
14.Yilma, T, Hsu, D, Jones, L et al. , Protection of cattle against rinderpest with infectious vaccinia virus recombinants expressing the HA or F genes. Science1988; 242: 1058–61.CrossRefGoogle Scholar
15
15.Baxby, D. Indications for smallpox vaccine: policies still differ. Vaccine1993; 11: 395–6.CrossRefGoogle ScholarPubMed
16
16.Baxby, D, Gaskell, RM, Gaskell, CJ, Bennett, M. Ecology of orthopoxviruses and use of recombinant vaccinia vaccines. Lancet1986; ii: 850–1.CrossRefGoogle Scholar
17
17.Tartaglia, J, Perkus, M, Taylor, J et al. , NYVAC: a highly attenuated strain of vaccinia virus. Virology1992; 188: 217–32.CrossRefGoogle ScholarPubMed
18
18.Esposito, JJ, Sumner, JW, Brown, D et al. , Raccoon poxvirus rabies-glycoprotein oral vaccine for wildlife; further efficacy studies and serosurvey for raccoon poxvirus. In: Brown, F, Chanock, RM, Ginsberg, H, Lerner, RA, eds. Vaccine '92. Cold Spring Harbor; Cold Spring Harbor Press, 1992; 321–9.Google Scholar
19.
19..Romero, CH, Barrett, T, Chamberlin, RW et al. , Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology1994; 204: 425–9.CrossRefGoogle ScholarPubMed
21.Cadoz, M, Strady, A, Meignier, B et al. , Immunization with canarypox virus expressing rabies glycoprotein. Lancet1992; 339: 1429–32.CrossRefGoogle ScholarPubMed
22
22.Baxby, D, Paoletti, E. Potential use of non-replicating vectors as recombinant vaccines. Vaccine1992; 10: 8–9.CrossRefGoogle ScholarPubMed